Contact information
Linda Wicker
Recent publications
-
Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes
Journal article
Zhang J-Y. et al, (2022), Nature Communications, 13
-
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes.
Journal article
Dunger DB. et al, (2022), Trials, 23
-
Low-dose IL-2 reduces IL-21+ T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients
Preprint
Zhang J-Y. et al, (2022)
-
Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73.
Journal article
Jarvis LB. et al, (2021), Commun Biol, 4
-
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Journal article
Robertson CC. et al, (2021), Nature genetics